Effectiveness of monovalent XBB.1.5-containing Covid-19 mRNA vaccines in the Nordic countries

First published 25/03/2024

Last updated 10/06/2024

EU PAS number:

EUPAS1000000043

Study

Finalised

Download as PDF

Documents

Study protocol

Updated protocol

EMA_ROC17 Option_Study protocol .pdf

First published: 13/03/2024

English (662.84 KB - PDF)View document

Study results

Study report

Study report

EMA ROC17 Option Study report.pdf

English (1.26 MB - PDF)View document

Other information

ENCePP Seal

ENCePP Seal documents